|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22,500 KRW | +1.58% |
|
+1.81% | -12.45% |
Kolon Life Science Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was KRW 119.89 million compared to KRW 103.06 million a year ago. Net loss was KRW 1,374.92 million compared to KRW 43,195.23 million a year ago.
Basic loss per share from continuing operations was KRW 121 compared to KRW 3,789 a year ago. Basic loss per share was KRW 121 compared to KRW 3,789 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.45% | 189M | |
| +38.59% | 727B | |
| -7.89% | 347B | |
| +15.66% | 319B | |
| +0.24% | 274B | |
| +13.47% | 238B | |
| +7.35% | 204B | |
| -6.42% | 203B | |
| +4.23% | 161B | |
| -1.70% | 160B |
KOLON LIFE SCIENCE INC. 
